As of 2025-05-29, the Gross Margin of Zhejiang Starry Pharmaceutical Co Ltd (603520.SS) is 23.1%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 23.1% |
2022-12-31 | 23.6% |
2021-12-31 | 37.2% |
2020-12-31 | 43.9% |
2019-12-31 | 42.6% |
2018-12-31 | 40.3% |
2017-12-31 | 37.4% |
2016-12-31 | 38% |
2015-12-31 | 37.1% |
2014-12-31 | 31.5% |